303 related articles for article (PubMed ID: 21029489)
1. [Skin abnormalities as first sign of Waldenström macroglobulinaemia].
Visser MF; Croon-de Boer F; Lonnee ER; Drees A
Ned Tijdschr Geneeskd; 2010; 154():A2097. PubMed ID: 21029489
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment with rituximab and thalidomide of POEMS syndrome associated with Waldenstrom macroglobulinemia.
Kawano Y; Nakama T; Hata H; Kimura E; Maruyoshi N; Uchino M; Mitsuya H
J Neurol Sci; 2010 Oct; 297(1-2):101-4. PubMed ID: 20673674
[TBL] [Abstract][Full Text] [Related]
3. [Therapy of Waldenström´s macroglobulinaemia in the year 2014].
Adam Z; Krejčí M; Pour L; Ševčíková E
Vnitr Lek; 2014 Feb; 60(2):139-57. PubMed ID: 24754419
[TBL] [Abstract][Full Text] [Related]
4. Alkylating Agents in the Treatment of Waldenström Macroglobulinemia.
Buske C
Hematol Oncol Clin North Am; 2018 Oct; 32(5):821-827. PubMed ID: 30190020
[TBL] [Abstract][Full Text] [Related]
5. Leukocytoclastic vasculitis as early manifestation of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly.
Zoroquiain P; González S; Molgó M; Rodríguez A; Valbuena JR
Am J Dermatopathol; 2012 May; 34(3):330-4. PubMed ID: 22197862
[TBL] [Abstract][Full Text] [Related]
6. [Pathology, diagnostics, and treatment of Waldenström's macroglobulinaemia].
Holmström MO
Ugeskr Laeger; 2011 Oct; 173(41):2557-60. PubMed ID: 21985832
[TBL] [Abstract][Full Text] [Related]
7. [Effective treatment with rituximab in two patients with Waldenström macroglobulinemia].
Yoshimi A; Arai S; Iijima K; Iki S; Usuki K; Urabe A
Rinsho Ketsueki; 2005 Oct; 46(10):1109-13. PubMed ID: 16440772
[TBL] [Abstract][Full Text] [Related]
8. Essential mixed cryoglobulinemia type III with leukocytoclastic vasculitis: remission by rituximab.
Baerlecken NT; Schmidt RE
Clin Rheumatol; 2013 Mar; 32 Suppl 1():S19-20. PubMed ID: 20213127
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment with Rituximab and Bendamustine in a patient with newly diagnosed Waldenström's Macroglobulinemia complicated by Bing-Neel syndrome.
Varettoni M; Marchioni E; Bonfichi M; Picchiecchio A; Arcaini L; Arbasino C; Gotti M; Da Vià M; Delmonte M; Sciarra R; Cazzola M
Am J Hematol; 2015 Aug; 90(8):E152-3. PubMed ID: 25975811
[No Abstract] [Full Text] [Related]
10. Cutaneous Waldenstrom's macroglobulinemia with "deck-chair" sign treated with cyclophosphamide.
Autier J; Buffet M; Pinquier L; Merlat-Guitard AI; Carlotti A; Franck N; Gorin I; Dupin N
J Am Acad Dermatol; 2005 Feb; 52(2 Suppl 1):45-7. PubMed ID: 15692513
[TBL] [Abstract][Full Text] [Related]
11. [Myelopathy manifesting as macroglobulinemia].
Woimant F; Schanen A; Bertail MA; Dupuy M; Lecoz P; Haguenau M; Pépin B
Ann Med Interne (Paris); 1985; 136(2):121-4. PubMed ID: 3935023
[TBL] [Abstract][Full Text] [Related]
12. Unusual manifestations of type II cryoglobulinaemia associated with Waldenström's macroglobulinaemia.
Blanco P; Viallard JF; Rivel J; Leng B; Pellegrin JL
J Clin Pathol; 2000 Nov; 53(11):882-4. PubMed ID: 11127277
[TBL] [Abstract][Full Text] [Related]
13. Bilateral episcleritis as a manifestation of cutaneous leukocytoclastic vasculitis.
Bollinger K; Medina C; Perez VL
Ocul Immunol Inflamm; 2009; 17(1):23-5. PubMed ID: 19294569
[TBL] [Abstract][Full Text] [Related]
14. [Polychimiotherapy and Waldenström's macroglobulinemia (author's transl)].
Barrier J; Grolleau JY; Renault JJ; Ozanne P; Bouret O
Sem Hop; 1979 Dec 8-15; 55(41-42):1925-6. PubMed ID: 231315
[TBL] [Abstract][Full Text] [Related]
15. [Changes in the prognosis and treatment of Waldenström macroglobulinemia. Literature overview and own experience].
Adam Z; Pour L; Krejčí M; Ševčíková S; Pourová E; Ševčíková E; Král Z; Mayer J
Vnitr Lek; 2016 Jan; 62(1):25-39. PubMed ID: 26967234
[TBL] [Abstract][Full Text] [Related]
16. Improvement of the thermal amplitude after rituximab treatment for cold agglutinin disease with Waldenström's macroglobulinemia.
Hattori N; Ishii N; Ariizumi H; Adachi D; Matsuda I; Nakamaki T; Tomoyasu S
Ann Hematol; 2010 Jan; 89(1):103-4. PubMed ID: 19513714
[No Abstract] [Full Text] [Related]
17. [Treatment of Waldenström macroglobulinaemia--the experience of one centre].
Adam Z; Pour L; Krejcí M; Korístek Z; Navrátil M; Krivanová A; Zahradová L; Hájek R
Vnitr Lek; 2009 Jan; 55(1):9-17. PubMed ID: 19227950
[TBL] [Abstract][Full Text] [Related]
18. Alpha-interferon therapy in advanced unresponsive immunoblastic lymphoma evolved from Waldenström's macroglobulinemia.
Carella AM
Haematologica; 1990; 75(6):581. PubMed ID: 1711503
[No Abstract] [Full Text] [Related]
19. Immunobullous dermatosis associated with Waldenström macroglobulinaemia treated with rituximab.
Chattopadhyay M; Rytina E; Dada M; Bhogal BS; Groves R; Handfield-Jones S
Clin Exp Dermatol; 2013 Dec; 38(8):866-9. PubMed ID: 23782150
[TBL] [Abstract][Full Text] [Related]
20. Waldenström macroglobulinaemia and intestinal lymphangiectasia.
Cooke RE; Kalnins RM; Ho WK
Br J Haematol; 2014 Nov; 167(3):292. PubMed ID: 25039993
[No Abstract] [Full Text] [Related]
[Next] [New Search]